Swiss neurologist partner in a European JPND project
The neurologist Hans Jung is partner in one of the projects selected for funding in the 2018 Call launched by the EU Joint Programme on Neurodegenerative Disease Research (JPND).
The 2018 JPND Call focused on health and social care for patients suffering from neurodegenerative diseases. The submitted projects were evaluated by an international Peer Review Panel and underwent a highly competitive selection. At the end of this process, ten projects were selected for funding.
Partners from six countries
Hans Jung from the University Hospital in Zurich will participate in the project "Multi-Domain Lifestyle Targets for Improving Prognosis in Huntington’s Disease" (DOMINO-HD). The SNSF will financially support his work for the next three years. The project will be co-ordinated from the UK and will benefit from the expertise of partners located in Germany, Ireland, Poland, Spain, and Switzerland. This consortium will investigate key environmental factors that may be responsive in targeted interventions with a view towards optimising disease management for individuals suffering from Huntington’s Disease.
EU JPND: Research on Neurodegenerative Disease
The EU Joint Programme on Neurodegenerative Disease Research seeks to increase coordinated investment between participating countries. The research supported by the JPND programme aims at finding causes, developing cures, and identifying appropriate ways to care for people affected by these diseases. The annual call for proposals launched in 2018 accepted applications for multinational and multidisciplinary collaborative research projects that address health and social care at both, the macro level of systems and infrastructures and the individual level of patients, carers and families.